Ipilimumab
Overview
Rho (D) Immune Globulin is a sterile solution of globulins derived from human plasma containing antibody to the erythrocyte factor Rh? (D) antigen. Rho (D) Immune Globulin is used to prevent a Rh-negative mother from forming antibodies to fetal Rh-positive cells which may pass into the maternal circulation. The objective is to protect any subsequent child from the hazard of the haemolytic disease of the newborn. Anti-D immunoglobulin should be administered following any sensitizing episode e.g abortion, miscarriage and birth.
Categories
No Categories Defined
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Drug Interactions
No data regarding the interactions of Rho (D) Immune Globulin was found.
Back to top
Side Effects
Back to top
Dosage
Ipilimumab's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 3 mg/kg | 3 (3) | As recommended. | IV | Administer IV over 90 minute period. patient should recieve entire regimen in dilution (4 doses) as tolerated. assessment of tumor response should be conducted only after therapy. LFT & TFT should be evaluated at baseline before each dose of ipilimumab. must not be administer as an IV push or bolus. can be given as a dilution of NaCl 9mg/ml (0.9%) solution for injection or glucose 50mg/ml (5%) solution for injection to concentration between 1 & 4 mg/ml. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Ipilimumab is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Ipilimumab is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Ipilimumab
Back to top
Previous Drug Generic - Next Drug Generic